Abstract:Renal fibrosis is an unavoidable end result of all forms of progressive chronic kidney diseases (CKD). Discovery of efficacious drugs against renal fibrosis is in crucial need. In a preliminary study we found that a derivative of artemisinin, dihydroartemisinin (DHA), exerted strong renoprotection, and reversed renal fibrosis in adenine-induced CKD mouse model. In this study we investigated the anti-fibrotic mechanisms of DHA, particularly its specific target in renal cells. Renal fibrosis was induced in mice by unilateral ureteral obstruction (UUO) or oral administration of adenine (80 mg · kg−1), the mice received DHA (30 mg · kg−1 · d−1, i.g.) for 14 or 21 days, respectively. We showed that DHA administration markedly attenuated the inflammation and fibrotic responses in the kidneys and significantly improved the renal function in both the renal fibrosis mouse models. In adenine-treated mice, DHA was more effective than 5-azacytidine against renal fibrosis. The anti-fibrotic effects of DHA were also observed in TGF-β1-treated HK-2 cells. In order to determine the target protein of DHA, we conducted pull-down technology coupled with shotgun proteomics using a small-molecule probe based on the structure of DHA (biotin-DHA). As a results, DNA methyltransferase 1 (DNMT1) was identified as the anti-fibrotic target of DHA in 3 different types of renal cell lines (HK-2, HEK293 and 3T3). We demonstrated that DHA directly bound to Asn 1529 and Thr 1528 of DNMT1 with a Kd value of 8.18 μM. In primary mouse renal tubular cells, we showed that DHA (10 μM) promoted DNMT1 degradation via the ubiquitin–proteasome pathway. DHA-reduced DNMT1 expression effectively reversed Klotho promoter hypermethylation, which led to the reversal of Klotho protein loss in the kidney of UUO mice. This subsequently resulted in inhibition of the Wnt/β-catenin and TGF-β/Smad signaling pathways and consequently conferred renoprotection in the animals. Knockdown of Klotho abolished the renoprotective effect of DHA in UUO mice. Our study reveals a novel pharmacological activity for DHA, i.e., renoprotection. DHA exhibits this effect by targeting DNMT1 to reverse Klotho repression. This study provides an evidence for the possible clinical application of DHA in the treatment of renal fibrosis.

Rhein Reversal of Dna Hypermethylation-Associated Klotho Suppression Ameliorates Renal Fibrosis in Mice

Rhein Reverses Klotho Repression Via Promoter Demethylation and Protects Against Kidney and Bone Injuries in Mice with Chronic Kidney Disease

TGFβ-incurred Epigenetic Aberrations of Mirna and DNA Methyltransferase Suppress Klotho and Potentiate Renal Fibrosis

Klotho Recovery by Genistein Via Promoter Histone Acetylation and DNA Demethylation Mitigates Renal Fibrosis in Mice

Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3 signalling pathway

Renal protection of rhein against 5/6 nephrectomied-induced chronic kidney disease: role of SIRT3-FOXO3α signalling pathway.

Klotho Preservation by Rhein Promotes Toll-Like Receptor 4 Proteolysis and Attenuates Lipopolysaccharide-Induced Acute Kidney Injury.

Cell and rat serum, urine and tissue metabolomics analysis elucidates the key pathway changes associated with chronic nephropathy and reveals the mechanism of action of rhein

Rhein, a novel Histone Deacetylase (HDAC) inhibitor with antifibrotic potency in human myocardial fibrosis

Rhein Improves Renal Fibrosis by Restoring Cpt1a-Mediated Fatty Acid Oxidation Through SirT1/STAT3/twist1 Pathway

Rhein Improves Renal Lesion and Ameliorates Dyslipidemia in Db/Db Mice with Diabetic Nephropathy

Inhibitory Effect of Rhein on Renal Fibrosis in Diabetic Nephropathy Rats

Rhein ameliorates transverse aortic constriction-induced cardiac hypertrophy via regulating STAT3 and p38 MAPK signaling pathways

Dihydroartemisinin suppresses renal fibrosis in mice by inhibiting DNA-methyltransferase 1 and increasing Klotho

Histone Deacetylase 3 Aberration Inhibits Klotho Transcription and Promotes Renal Fibrosis

Nanoparticle-mediated Klotho Gene Therapy Prevents Acute Kidney Injury to Chronic Kidney Disease Transition Through Regulating PPARα Signaling in Renal Tubular Epithelial Cells

Rhein Inhibits Renal Tubular Epithelial Cell Hypertrophy and Extracellular Matrix Accumulation Induced by Transforming Growth Factor Beta1.

Rhein Protects 5/6 Nephrectomized Rat Against Renal Injury by Reducing Inflammation Via NF-κB Signaling

Anti-Hyperuricemic and Nephroprotective Effects of Rhein in Hyperuricemic Mice

MicroRNA-34a Promotes Renal Fibrosis by Downregulation of Klotho in Tubular Epithelial Cells

Klotho retards renal fibrosis through targeting mitochondrial dysfunction and cellular senescence in renal tubular cells